David D. Leedahl

436 total citations
25 papers, 294 citations indexed

About

David D. Leedahl is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David D. Leedahl has authored 25 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Epidemiology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David D. Leedahl's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Antibiotic Use and Resistance (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). David D. Leedahl is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Antibiotic Use and Resistance (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). David D. Leedahl collaborates with scholars based in United States, Croatia and Israel. David D. Leedahl's co-authors include Erin F. Barreto, Kianoush Kashani, Paul J. Carson, Garrett E. Schramm, Lakhmir S. Chawla, Eric J. Bergstralh, Cornelius Dyke, Ross Dierkhising, Eric Anderson and Alexander Drofa and has published in prestigious journals such as The American Journal of Surgery, Clinical Journal of the American Society of Nephrology and The Pediatric Infectious Disease Journal.

In The Last Decade

David D. Leedahl

25 papers receiving 285 citations

Peers

David D. Leedahl
David D. Leedahl
Citations per year, relative to David D. Leedahl David D. Leedahl (= 1×) peers Melda Türkoğlu

Countries citing papers authored by David D. Leedahl

Since Specialization
Citations

This map shows the geographic impact of David D. Leedahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Leedahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Leedahl more than expected).

Fields of papers citing papers by David D. Leedahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D. Leedahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Leedahl. The network helps show where David D. Leedahl may publish in the future.

Co-authorship network of co-authors of David D. Leedahl

This figure shows the co-authorship network connecting the top 25 collaborators of David D. Leedahl. A scholar is included among the top collaborators of David D. Leedahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. Leedahl. David D. Leedahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leedahl, David D., et al.. (2022). Pharmacist-managed multistep order transmittal for electronic specialty prescriptions reduces represcribing burden in ambulatory clinics: A retrospective cohort pilot study. Journal of Managed Care & Specialty Pharmacy. 28(7). 778–785. 1 indexed citations
2.
Roth, Felix, et al.. (2022). Clinical and Financial Impact of Rapid Antimicrobial Susceptibility Testing in Blood Cultures. Antibiotics. 11(2). 122–122. 6 indexed citations
3.
Petry, Natasha, et al.. (2021). Impact of Automated Best Practice Advisories on Provider Response to CYP2C19 Genotyping Results for Patients on Clopidogrel. Journal of Pharmacy Practice. 36(3). 487–493. 6 indexed citations
4.
Lopez, Santiago M. C., et al.. (2020). Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas. Epidemiology and Infection. 148. e124–e124. 16 indexed citations
5.
Leedahl, David D., et al.. (2020). Comparison of Anticoagulants for Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Pilot Study. Journal of Cardiovascular Pharmacology and Therapeutics. 25(6). 523–530. 15 indexed citations
6.
Leedahl, David D., et al.. (2019). Impact of a Comprehensive COPD Therapeutic Interchange Program on 30-Day Readmission Rates in Hospitalized Patients.. PubMed. 44(4). 185–191. 4 indexed citations
7.
Leedahl, David D., et al.. (2019). Outcomes Associated With Standardized Ideal Body Weight Dosing of Intravenous Immune Globulin in Hospitalized Patients: A Multicenter Study. Annals of Pharmacotherapy. 54(3). 205–212. 10 indexed citations
8.
Brown, Gary L., et al.. (2018). Effectiveness of Umeclidinium-Vilanterol for Protocolized Management of Chronic Obstructive Pulmonary Disease Exacerbation in Hospitalized Patients: A Sequential Period Analysis. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 5(1). 38–45. 4 indexed citations
9.
Samaniego, Edgar A., Aldo A. Mendez, Thanh N. Nguyen, et al.. (2018). LVIS Jr Device for Y-Stent-Assisted Coil Embolization of Wide-Neck Intracranial Aneurysms: A Multicenter Experience. Interventional Neurology. 7(5). 271–283. 38 indexed citations
10.
Leedahl, David D., et al.. (2018). Prevention of Clostridium difficile Infection in Critically Ill Adults. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 39(3). 399–407. 4 indexed citations
11.
Leedahl, David D., et al.. (2018). Impact of a multicenter stewardship‐targeted carbapenem justification requirement on the use of carbapenems in 23 hospitals. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2(1). 53–57. 2 indexed citations
12.
Carson, Paul J., et al.. (2018). Failure of a Best Practice Alert to Reduce Antibiotic Prescribing Rates for Acute Sinusitis Across an Integrated Health System in the Midwest. Journal of Managed Care & Specialty Pharmacy. 24(2). 154–159. 20 indexed citations
13.
Drofa, Alexander, et al.. (2017). A Case Series of 18 Patients Receiving Ticagrelor After Carotid Stenting. Journal of Pharmacy Practice. 31(5). 519–521. 6 indexed citations
14.
Leedahl, David D., et al.. (2016). Association Between Updated Guideline-Based Palivizumab Administration and Hospitalizations for Respiratory Syncytial Virus Infections. The Pediatric Infectious Disease Journal. 35(7). 728–732. 17 indexed citations
15.
Anderson, Eric, et al.. (2015). Novel oral anticoagulants vs warfarin for the management of postoperative atrial fibrillation: clinical outcomes and cost analysis. The American Journal of Surgery. 210(6). 1095–1103. 27 indexed citations
16.
Leedahl, David D., et al.. (2015). Successful hemostasis and reversal of highly elevated PT/INR after dabigatran etexilate use in a patient with acute kidney injury. The American Journal of Emergency Medicine. 34(4). 758.e5–758.e6. 6 indexed citations
17.
Richter, Lisa, et al.. (2015). Desensitization to ceftaroline in a patient with multiple medication hypersensitivity reactions. American Journal of Health-System Pharmacy. 72(3). 198–202. 4 indexed citations
18.
Leedahl, David D., Erin F. Barreto, Garrett E. Schramm, et al.. (2014). Derivation of Urine Output Thresholds That Identify a Very High Risk of AKI in Patients with Septic Shock. Clinical Journal of the American Society of Nephrology. 9(7). 1168–1174. 46 indexed citations
19.
Leedahl, David D., Heather A. Personett, Ognjen Gajic, Rahul Kashyap, & Garrett E. Schramm. (2014). Predictors of mortality among bacteremic patients with septic shock receiving appropriate antimicrobial therapy. BMC Anesthesiology. 14(1). 21–21. 9 indexed citations
20.
Leedahl, David D., Julie L. Cunningham, Matthew T. Drake, et al.. (2012). Hypovitaminosis D in Psychiatric Inpatients: Clinical Correlation with Depressive Symptoms, Cognitive Impairment, and Prescribing Practices. Psychosomatics. 54(3). 257–262. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026